Analogic Corporation designs, manufactures, and sells medical imaging systems, ultrasound and security systems, and subsystems to original equipment manufacturers (OEMs) and end users primarily for the medical and airport security markets worldwide. It operates in three segments: Medical Imaging, Ultrasound, and Security and Detection. The Medical Imaging segment offers computed tomography (CT) detector systems, data acquisition systems, data management systems, and integrated CT systems; magnetic resonance imaging products, including gradient and radio frequency amplifiers; and digital mammography products, such as detector plates, as well as motion control devices for use in computer-controlled automation systems primarily for the semiconductor, food and beverage, and laboratory automation markets. This segment sells its products through multinational OEMs. The Ultrasound segment designs and manufactures medical ultrasound systems under the BK Ultrasound brand for use in urology, surgery, point-of-care, anesthesia, and general imaging applications. It also provides its products for cardiology, radiology, OB/GYN, surgery, and interventional radiology applications, as well as offers various transducers. This segment sells its products through its direct sales force, as well as through a network of independent sales representatives and distributors. The Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications. It provides checked baggage, checkpoint CT, and high speed in-line baggage handling systems; and rapid DNA analysis systems to analyze multiple human DNA samples. This segment sells its products primarily through multinational partners. Analogic Corporation has a partnership agreement with Stratovan Corporation. The company was founded in 1967 and is headquartered in Peabody, Massachusetts.
Industry, Sector and Symbol
Industry Instruments to measure electricity
Sub-IndustryHealth Care Equipment
SectorComputer and Technology
SymbolNASDAQ:ALOG
CUSIP03265720
Phone978-326-4000
Debt
Debt-to-Equity RatioN/A
Current Ratio5.15
Quick Ratio3.51
Price-To-Earnings
Trailing P/E Ratio48.81
Forward P/E Ratio19.85
P/E Growth2.84
Sales & Book Value
Annual Sales$486.37 million
Price / Sales2.16
Cash Flow$3.7015 per share
Price / Cash22.68
Book Value$38.65 per share
Price / Book2.17
Profitability
EPS (Most Recent Fiscal Year)$1.72
Net Income$-74,230,000.00
Net Margins-1.13%
Return on Equity6.77%
Return on Assets5.75%
Miscellaneous
Employees1,510
Outstanding Shares12,500,000
Analogic (NASDAQ:ALOG) Frequently Asked Questions
What is Analogic's stock symbol?
Analogic trades on the NASDAQ under the ticker symbol "ALOG."
How often does Analogic pay dividends? What is the dividend yield for Analogic?
Analogic declared a quarterly dividend on Monday, March 5th. Investors of record on Thursday, March 15th will be given a dividend of $0.10 per share on Monday, March 26th. This represents a $0.40 annualized dividend and a dividend yield of 0.48%. The ex-dividend date is Wednesday, March 14th. View Analogic's Dividend History.
How were Analogic's earnings last quarter?
Analogic Co. (NASDAQ:ALOG) announced its earnings results on Monday, June, 4th. The medical research company reported $1.08 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.97 by $0.11. The medical research company earned $119.97 million during the quarter, compared to analyst estimates of $113.60 million. Analogic had a negative net margin of 1.13% and a positive return on equity of 6.77%. View Analogic's Earnings History.
When is Analogic's next earnings date?
What price target have analysts set for ALOG?
1 Wall Street analysts have issued 12 month price objectives for Analogic's shares. Their predictions range from $80.00 to $80.00. On average, they anticipate Analogic's share price to reach $80.00 in the next twelve months. View Analyst Ratings for Analogic.
Who are some of Analogic's key competitors?
Who are Analogic's key executives?
Analogic's management team includes the folowing people:
- Dr. Fred B. Parks, Chief Exec. Officer, Pres and Director (Age 71)
- Mr. Michael J. Bourque, Sr. VP, CFO, Chief Accounting Officer & Treasurer (Age 55)
- Mr. John J. Fry, Sr. VP, Gen. Counsel & Sec. (Age 57)
- Mrs. Mervat Faltas, Sr. VP & GM of Medical Imaging Bus. (Age 66)
- Mr. Mark Namaroff, Sr. Director of Investor Relations & Corp. Communications (Age 55)
Has Analogic been receiving favorable news coverage?
Media stories about ALOG stock have been trending positive on Thursday, according to Accern. Accern ranks the sentiment of press coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Analogic earned a media sentiment score of 0.28 on Accern's scale. They also gave media coverage about the medical research company an impact score of 46.34 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the near term.
Who are Analogic's major shareholders?
Analogic's stock is owned by many different of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (13.55%), Dimensional Fund Advisors LP (6.48%), Wells Fargo & Company MN (5.15%), Northern Trust Corp (2.97%), Schwab Charles Investment Management Inc. (1.29%) and Fort Washington Investment Advisors Inc. OH (1.15%). Company insiders that own Analogic stock include Bernard C Bailey, James Patrick Ryan, James W Green, Jeffrey P Black, John J Fry, Mervat Faltas and Shalabh Chandra. View Institutional Ownership Trends for Analogic.
Which institutional investors are selling Analogic stock?
ALOG stock was sold by a variety of institutional investors in the last quarter, including Neuberger Berman Group LLC, Dimensional Fund Advisors LP, Comerica Bank, Wells Fargo & Company MN, Natixis Advisors L.P., Citadel Advisors LLC, Systematic Financial Management LP and Envestnet Asset Management Inc.. View Insider Buying and Selling for Analogic.
Which institutional investors are buying Analogic stock?
ALOG stock was acquired by a variety of institutional investors in the last quarter, including American Century Companies Inc., Prudential Financial Inc., Hsbc Holdings PLC, Russell Investments Group Ltd., Fort Washington Investment Advisors Inc. OH, BlackRock Inc., Schwab Charles Investment Management Inc. and Chicago Equity Partners LLC. View Insider Buying and Selling for Analogic.
How do I buy shares of Analogic?
Shares of ALOG can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Analogic's stock price today?
One share of ALOG stock can currently be purchased for approximately $83.95.
How big of a company is Analogic?
Analogic has a market capitalization of $1.05 billion and generates $486.37 million in revenue each year. The medical research company earns $-74,230,000.00 in net income (profit) each year or $1.72 on an earnings per share basis. Analogic employs 1,510 workers across the globe.
How can I contact Analogic?
Analogic's mailing address is 8 CENTENNIAL DRIVE, PEABODY MA, 01960. The medical research company can be reached via phone at 978-326-4000 or via email at [email protected]
MarketBeat Community Rating for Analogic (ALOG)
MarketBeat's community ratings are surveys of what our community members think about Analogic and other stocks. Vote "Outperform" if you believe ALOG will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALOG will underperform the S&P 500 over the long term. You may vote once every thirty days.
